Contemporary medical, device, and surgical therapies for obesity in adults

CM Perdomo, RV Cohen, P Sumithran, K Clément… - The Lancet, 2023 - thelancet.com
The goal of obesity management is to improve health. Sustained weight loss of more than
10% overall bodyweight improves many of the complications associated with obesity (eg …

What is the pipeline for future medications for obesity?

E Melson, U Ashraf, D Papamargaritis… - International Journal of …, 2024 - nature.com
Obesity is a chronic disease associated with increased risk of obesity-related complications
and mortality. Our better understanding of the weight regulation mechanisms and the role of …

2020 expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of …

SR Das, BM Everett, KK Birtcher, JM Brown… - Journal of the American …, 2020 - jacc.org
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk
Reduction in Patients With Type 2 Diabetes: A Report of the American College of …

Safety and efficacy of liraglutide, 3.0 mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical …

J Mok, MO Adeleke, A Brown, CG Magee… - JAMA …, 2023 - jamanetwork.com
Importance Metabolic surgery leads to weight loss and improved health, but these outcomes
are highly variable. Poor weight loss is associated with lower circulating levels of glucagon …

Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients …

F Rubino, RV Cohen, G Mingrone… - The Lancet Diabetes & …, 2020 - thelancet.com
The coronavirus disease 2019 pandemic is wreaking havoc on society, especially health-
care systems, including disrupting bariatric and metabolic surgery. The current limitations on …

[HTML][HTML] Comprehensive review of current and upcoming anti-obesity drugs

JW Son, S Kim - Diabetes & metabolism journal, 2020 - synapse.koreamed.org
Obesity is among the leading causes of morbidity and mortality worldwide and its
prevalence continues to increase globally. Because obesity is a chronic, complex, and …

Efficacy of the glucagon-like peptide-1 receptor agonists liraglutide and semaglutide for the treatment of weight regain after bariatric surgery: a retrospective …

AB Jensen, F Renström, S Aczél, P Folie… - Obesity surgery, 2023 - Springer
Purpose Weight regain after bariatric surgery occurs in up to a third of patients and reduces
treatment-associated health benefits. The efficacy of glucagon-like peptide-1 receptor …

[HTML][HTML] Evaluation and treatment of obesity and its comorbidities: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity

KK Kim, JH Haam, BT Kim, EM Kim… - Journal of Obesity & …, 2023 - ncbi.nlm.nih.gov
The goal of the 8th edition of the Clinical Practice Guidelines for Obesity is to help primary
care physician provide safe, effective care to patients with obesity by offering evidence …

[HTML][HTML] The antidepressant effects of GLP-1 receptor agonists: a systematic review and meta-analysis

X Chen, P Zhao, W Wang, L Guo, Q Pan - The American Journal of …, 2024 - Elsevier
ABSTRACT Aim/Hypothesis Emerging evidence suggests that glucagon-like peptide-1
receptor agonists (GLP-1RAs) may exert positive effects in patients with depression. Our aim …

Effectiveness of semaglutide versus liraglutide for treating post‐metabolic and bariatric surgery weight recurrence

N Murvelashvili, L **e, JN Schellinger, MS Mathew… - …, 2023 - Wiley Online Library
Objective The aim of this study was to compare the effectiveness of semaglutide versus
liraglutide for treating post‐metabolic and bariatric surgery (MBS) weight recurrence …